Vidarabine
PubChem Notes:
Vidarabine A nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the VACCINIA VIRUS and varicella zoster virus.
Molecular Formula:
C10H13N5O4
InChI: InChI=1/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6+,7+,10?/m1/s1/f/h11H2
InChIKey: InChIKey=OIRDTQYFTABQOQ-TWPZHVHYDI
SMILES: C1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)CO)O)O
Names:
Prestwick_983
Vidarabine
(3S,4R,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
5536-17-4
Registries:
PubChem CID 6420052
PubChem ID 10321892
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|